Activity of trimethoprim-sulfamethoxazole against Chlamydia trachomatis in vitro
- PMID: 6981168
- DOI: 10.1093/clinids/4.2.500
Activity of trimethoprim-sulfamethoxazole against Chlamydia trachomatis in vitro
Abstract
With use of a technique for cell culture, the minimal inhibitory concentration (MICs) of trimethoprim (TMP) and sulfamethoxazole (SMZ), alone and in combination at ratios of 1:1, 1:5, and 1:20, were determined against five strains of Chlamydia trachomatis. The drugs were added to idoxuridine-treated McCoy cells after inoculation of the cells with the pathogen. Cultures were examined after incubation for 48 hr; the MIC was defined as the highest concentration of drugs at which no inclusions were seen. Definite end points were observed only with inocula of less than or equal to 10(3) inclusion-forming units (IFU)/ml. With larger inocula, inclusions were present for all dilutions tested. The MICs for TMP alone were greater than or equal to 64 micrograms/ml for all strains. The MICs for SMZ alone ranged from 2 to 128 micrograms/ml. There appeared to be no better than an additive effect for all combinations of TMP and SMZ tested, although the effect of 1:20 was greater than that at 1:1 or 1:5. With increasing concentrations of both drugs, the inclusions became progressively fewer, smaller, and pyknotic. Even though definite end points could not be determined, there was a significant reduction in the number of IFU/ml at relatively low concentrations of both TMP and SMZ. The results of this study suggest that the activity of TMP-SMZ against C. trachomatis is primarily that of SMZ alone.
Similar articles
-
In vitro activity of trimethoprim and sulfamethoxazole against the nontuberculous mycobacteria.Rev Infect Dis. 1982 Mar-Apr;4(2):326-31. doi: 10.1093/clinids/4.2.326. Rev Infect Dis. 1982. PMID: 7111959
-
In vitro additive effect of nitrofurantoin combined with trimethoprim-sulfamethoxazole against Serratia marcescens.Chemotherapy. 1979;25(3):140-6. doi: 10.1159/000237833. Chemotherapy. 1979. PMID: 378572
-
Treatment of concomitant Neisseria gonorrhoeae and Chlamydia trachomatis infections in women: comparison of trimethoprim-sulfamethoxazole with ampicillin-probenecid.Rev Infect Dis. 1982 Mar-Apr;4(2):491-9. doi: 10.1093/clinids/4.2.491. Rev Infect Dis. 1982. PMID: 6981167 Clinical Trial.
-
Use of trimethoprim-sulfamethoxazole singly and in combination with other antibiotics in immunocompromised patients.Rev Infect Dis. 1987 Mar-Apr;9 Suppl 2:S177-83. doi: 10.1093/clinids/9.supplement_2.s177. Rev Infect Dis. 1987. PMID: 3554456 Review.
-
Use of trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonitis in patients with acquired immunodeficiency syndrome.Rev Infect Dis. 1987 Mar-Apr;9 Suppl 2:S184-94. doi: 10.1093/clinids/9.supplement_2.s184. Rev Infect Dis. 1987. PMID: 3554457 Review.
Cited by
-
Evaluating the Antibiotic Susceptibility of Chlamydia - New Approaches for in Vitro Assays.Front Microbiol. 2018 Jul 3;9:1414. doi: 10.3389/fmicb.2018.01414. eCollection 2018. Front Microbiol. 2018. PMID: 30018602 Free PMC article.
-
Ultrastructural study of Chlamydia pneumoniae in a continuous-infection model.J Clin Microbiol. 2001 Oct;39(10):3721-3. doi: 10.1128/JCM.39.10.3721-3723.2001. J Clin Microbiol. 2001. PMID: 11574601 Free PMC article.
-
Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis.Microbiol Rev. 1994 Dec;58(4):686-99. doi: 10.1128/mr.58.4.686-699.1994. Microbiol Rev. 1994. PMID: 7854252 Free PMC article. Review.
-
In vitro activity of a novel diaminopyrimidine compound, iclaprim, against Chlamydia trachomatis and C. pneumoniae.Antimicrob Agents Chemother. 2004 May;48(5):1885-6. doi: 10.1128/AAC.48.5.1885-1886.2004. Antimicrob Agents Chemother. 2004. PMID: 15105151 Free PMC article.
-
Treatment of acute gonococcal urethritis in men with simultaneous infection with Chlamydia trachomatis.Br J Vener Dis. 1984 Apr;60(2):95-8. doi: 10.1136/sti.60.2.95. Br J Vener Dis. 1984. PMID: 6367888 Free PMC article. Clinical Trial.